Canadian study raises more alarm bells about diabetes drug Avandia
A Canadian study is adding to concerns about the safety of a class of drugs for Type 2 diabetes after at least one of the medications appeared to raise the risk of heart failure, heart attack and death in older patients.
The study by the Institute for Clinical Evaluative Sciences (ICES) ...
